Psychiatric drugs bind to classical targets within early exocytotic pathways: Therapeutic effects

Biological Psychiatry

Volumn 72, Issue 11, 2012, Pages 907-915

  Lester, Henry A ^a   Miwa, Julie M ^a   Srinivasan, Rahul ^a  

^a CALIFORNIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Antipsychotics; depression; gene activation; nicotine; schizophrenia; serotonin selective reuptake inhibitors

Indexed keywords

ANTIDEPRESSANT AGENT; CYTISINE; DIHYDRO BETA ERYTHROIDINE; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR BLOCKING AGENT; DOPAMINE 2 RECEPTOR STIMULATING AGENT; DOPAMINE 3 RECEPTOR; G PROTEIN COUPLED RECEPTOR; HETERODIMER; HOMODIMER; KETAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROLEPTIC AGENT; NICOTINE; NICOTINIC RECEPTOR; SEROTONIN 2A RECEPTOR; SEROTONIN UPTAKE INHIBITOR;

AGRANULOCYTOSIS; CELL INTERACTION; DRUG ACTIVITY; DRUG EFFECT; DRUG MECHANISM; DRUG RECEPTOR BINDING; DRUG TARGETING; DYSKINESIA; ENDOPLASMIC RETICULUM STRESS; GENE ACTIVATION; HUMAN; NERVE FIBER TRANSPORT; NEUROPROTECTION; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN FOLDING; PROTEIN HOMEOSTASIS; PROTEIN SYNTHESIS; REVIEW; SIDE EFFECT; THERAPY EFFECT; UNSPECIFIED SIDE EFFECT; WEIGHT GAIN;

ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; ENDOPLASMIC RETICULUM; EXOCYTOSIS; GOLGI APPARATUS; PROTEIN TRANSPORT;

EID: 84868200466     PISSN: 00063223     EISSN: 18732402     Source Type: Journal    
DOI: 10.1016/j.biopsych.2012.05.020     Document Type: Review

References (100)

1. T.P. Su, T. Hayashi, T. Maurice, S. Buch, A.E. Ruoho The sigma-1 receptor chaperone as an inter-organelle signaling modulator Trends Pharmacol Sci 31 2010 557 566
2. K.E. Routledge, V. Gupta, W.E. Balch Emergent properties of proteostasis-COPII coupled systems in human health and disease Mol Membr Biol 27 2010 385 397
3. J. Sallette, S. Pons, A. Devillers-Thiery, M. Soudant, L. Prado de Carvalho, J.P. Changeux, P.J. Corringer Nicotine upregulates its own receptors through enhanced intracellular maturation Neuron 46 2005 595 607
4. A. Kuryatov, J. Luo, J. Cooper, J. Lindstrom Nicotine acts as a pharmacological chaperone to up-regulate human α4β2 acetylcholine receptors Mol Pharmacol 68 2005 1839 1851
5. H.A. Lester, C. Xiao, R. Srinivasan, C. Son, J. Miwa, R. Pantoja Nicotine is a selective pharmacological chaperone of acetylcholine receptor number and stoichiometry Implications for drug discovery AAPS J 11 2009 167 177
6. J.M. Miwa, R. Freedman, H.A. Lester Neural systems governed by nicotinic acetylcholine receptors: Emerging hypotheses Neuron 70 2011 20 33
7. W.E. Balch, R.I. Morimoto, A. Dillin, J.W. Kelly Adapting proteostasis for disease intervention Science 319 2008 916 919
8. P. Walter, D. Ron The unfolded protein response: From stress pathway to homeostatic regulation Science 334 2011 1081 1086
9. R.L. Wiseman, C.M. Haynes, D. Ron SnapShot: The unfolded protein response Cell 140 2010 590 590.e2
10. G. Zanetti, K.B. Pahuja, S. Studer, S. Shim, R. Schekman COPII and the regulation of protein sorting in mammals Nat Cell Biol 14 2012 20 28
11. J. Maiuolo, S. Bulotta, C. Verderio, R. Benfante, N. Borgese Selective activation of the transcription factor ATF6 mediates endoplasmic reticulum proliferation triggered by a membrane protein Proc Natl Acad Sci U S A 108 2011 7832 7837
12. P. Chen, A.J. Burdette, J.C. Porter, J.C. Ricketts, S.A. Fox, F.C. Nery The early-onset torsion dystonia-associated protein, torsinA, is a homeostatic regulator of endoplasmic reticulum stress response Hum Mol Genet 19 2010 3502 3515
13. S. Hummasti, G.S. Hotamisligil Endoplasmic reticulum stress and inflammation in obesity and diabetes Circ Res 107 2010 579 591
14. S. Matus, L.H. Glimcher, C. Hetz Protein folding stress in neurodegenerative diseases: A glimpse into the ER Curr Opin Cell Biol 23 2011 239 252
15. M. Nassif, S. Matus, K. Castillo, C. Hetz Amyotrophic lateral sclerosis pathogenesis: A journey through the secretory pathway Antioxid Redox Signal 13 2010 1955 1989
16. R. Srinivasan, C.I. Richards, C. Xiao, D. Rhee, R. Pantoja, D.A. Dougherty Pharmacological chaperoning of nicotinic acetylcholine receptors reduces the ER stress response Mol Pharmacol 81 2012 759 769
17. J.D. Mancias, J. Goldberg Structural basis of cargo membrane protein discrimination by the human COPII coat machinery EMBO J 27 2008 2918 2928
18. W.S. Young 3rd, J.K. Wamsley, M.A. Zarbin, M.J. Kuhar Opioid receptors undergo axonal flow Science 210 1980 76 78
19. B.L. Roth, M.B. Laskowski, C.J. Coscia Microsomal opiate receptors differ from synaptic membrane receptors in proteolytic sensitivity Brain Res 250 1982 101 109
20. B.L. Roth, C.J. Coscia Microsomal opiate receptors: Characterization of smooth microsomal and synaptic membrane opiate receptors J Neurochem 42 1984 1677 1684
21. 3 receptors Arch Pharm Res 33 2010 1521 1538
22. S.R. Sesack, C. Aoki, V.M. Pickel Ultrastructural localization of D2 receptor-like immunoreactivity in midbrain dopamine neurons and their striatal targets J Neurosci 14 1994 88 106
23. V. Cornea-Hebert, K.C. Watkins, B.L. Roth, W.K. Kroeze, P. Gaudreau, N. Leclerc, L. Descarries Similar ultrastructural distribution of the 5-HT2A serotonin receptor and microtubule-associated protein MAP1A in cortical dendrites of adult rat Neuroscience 113 2002 23 35
24. V. Cornea-Hebert, M. Riad, C. Wu, S.K. Singh, L. Descarries Cellular and subcellular distribution of the serotonin 5-HT2A receptor in the central nervous system of adult rat J Comp Neurol 409 1999 187 209
25. M.D. Doherty, V.M. Pickel Ultrastructural localization of the serotonin 2A receptor in dopaminergic neurons in the ventral tegmental area Brain Res 864 2000 176 185
26. N. Egawa, K. Yamamoto, H. Inoue, R. Hikawa, K. Nishi, K. Mori, R. Takahashi The endoplasmic reticulum stress sensor, ATF6α, protects against neurotoxin-induced dopaminergic neuronal death J Biol Chem 286 2011 7947 7957
27. 2A serotonin receptor biology: Interacting proteins, kinases and paradoxical regulation Neuropharmacology 61 2011 348 354
28. P.N. Yadav, W.K. Kroeze, M.S. Farrell, B.L. Roth Antagonist functional selectivity: 5-HT2A serotonin receptor antagonists differentially regulate 5-HT2A receptor protein level in vivo J Pharmacol Exp Ther 339 2011 99 105
29. L. Malaga-Dieguez, Q. Yang, J. Bauer, H. Pankevych, M. Freissmuth, C. Nanoff Pharmacochaperoning of the A1 adenosine receptor is contingent on the endoplasmic reticulum Mol Pharmacol 77 2010 940 952
30. K. Van Craenenbroeck, S.D. Clark, M.J. Cox, J.N. Oak, F. Liu, H.H. Van Tol Folding efficiency is rate-limiting in dopamine D4 receptor biogenesis J Biol Chem 280 2005 19350 19357
31. P.M. Conn, A. Ulloa-Aguirre Pharmacological chaperones for misfolded gonadotropin-releasing hormone receptors Adv Pharmacol 62 2011 109 141
32. S.M. Noorwez, D.A. Ostrov, J.H. McDowell, M.P. Krebs, S. Kaushal A high-throughput screening method for small-molecule pharmacologic chaperones of misfolded rhodopsin Invest Ophthalmol Vis Sci 49 2008 3224 3230
33. T.T. Leskela, J.J. Lackman, M.M. Vierimaa, H. Kobayashi, M. Bouvier, U.E. Petaja-Repo Cys-27 variant of human δ-opioid receptor modulates maturation and cell surface delivery of Phe-27 variant via heteromerization J Biol Chem 287 2012 5008 5020
34. V. Chaipatikul, L.J. Erickson-Herbrandson, H.H. Loh, P.Y. Law Rescuing the traffic-deficient mutants of rat μ-opioid receptors with hydrophobic ligands Mol Pharmacol 64 2003 32 41
35. J. Fan, S.J. Perry, Y. Gao, S.A. Schwarz, R.A. Maki A point mutation in the human melanin concentrating hormone receptor 1 reveals an important domain for cellular trafficking Mol Endocrinol 19 2005 2579 2590
36. Y.X. Tao The melanocortin-4 receptor: Physiology, pharmacology, and pathophysiology Endocr Rev 31 2010 506 543
37. S.R. Hawtin Pharmacological chaperone activity of SR49059 to functionally recover misfolded mutations of the vasopressin V1a receptor J Biol Chem 281 2006 14604 14614
38. J. Robert, C. Auzan, M.A. Ventura, E. Clauser Mechanisms of cell-surface rerouting of an endoplasmic reticulum-retained mutant of the vasopressin V1b/V3 receptor by a pharmacological chaperone J Biol Chem 280 2005 42198 42206
39. S. Wuller, B. Wiesner, A. Loffler, J. Furkert, G. Krause, R. Hermosilla Pharmacochaperones post-translationally enhance cell surface expression by increasing conformational stability of wild-type and mutant vasopressin V2 receptors J Biol Chem 279 2004 47254 47263
40. T. Kenakin G protein coupled receptors as allosteric proteins and the role of allosteric modulators J Recept Signal Transduct Res 30 2010 313 321
41. T. Kenakin, L.J. Miller Seven transmembrane receptors as shapeshifting proteins: The impact of allosteric modulation and functional selectivity on new drug discovery Pharmacol Rev 62 2010 265 304
42. E. Reiter, S. Ahn, A.K. Shukla, R.J. Lefkowitz Molecular mechanism of β-arrestin-biased agonism at seven-transmembrane receptors Annu Rev Pharmacol Toxicol 52 2012 179 197
43. J. Sun, V. Singh, R. Kajino-Sakamoto, A. Aballay Neuronal GPCR controls innate immunity by regulating noncanonical unfolded protein response genes Science 332 2011 729 732
44. 2 receptor Eur J Pharmacol 659 2011 114 123
45. L. Albizu, T. Holloway, J. Gonzalez-Maeso, S.C. Sealfon Functional crosstalk and heteromerization of serotonin 5-HT2A and dopamine D2 receptors Neuropharmacology 61 2011 770 777
46. J. Gonzalez-Maeso, R.L. Ang, T. Yuen, P. Chan, N.V. Weisstaub, J.F. Lopez-Gimenez Identification of a serotonin/glutamate receptor complex implicated in psychosis Nature 452 2008 93 97
47. M. Fribourg, J.L. Moreno, T. Holloway, D. Provasi, L. Baki, R. Mahajan Decoding the signaling of a GPCR heteromeric complex reveals a unifying mechanism of action of antipsychotic drugs Cell 147 2011 1011 1023
48. S.T. Patil, L. Zhang, F. Martenyi, S.L. Lowe, K.A. Jackson, B.V. Andreev Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: A randomized phase 2 clinical trial Nat Med 13 2007 1102 1107
49. B.J. Kinon, L. Zhang, B.A. Millen, O.O. Osuntokun, J.E. Williams, S. Kollack-Walker A multicenter, inpatient, phase 2, double-blind, placebo-controlled dose-ranging study of LY2140023 monohydrate in patients with DSM-IV schizophrenia J Clin Psychopharmacol 31 2011 349 355
50. S. Lowe, R. Dean, B. Ackermann, K. Jackson, F. Natanegara, S. Anderson Effects of a novel mGlu/receptor agonist prodrug, LY2140023 monohydrate, on central monoamine turnover as determined in human and rat cerebrospinal fluid Psychopharmacology (Berl) 219 2012 959 970
51. M. Hosokawa Structure and catalytic properties of carboxylesterase isozymes involved in metabolic activation of prodrugs Molecules 13 2008 412 431
52. Y.J. Jong, V. Kumar, K.L. O'Malley Intracellular metabotropic glutamate receptor 5 (mGluR5) activates signaling cascades distinct from cell surface counterparts J Biol Chem 284 2009 35827 35838
53. Z.A. Hughes, S.J. Neal, D.L. Smith, S.J. Sukoff Rizzo, C.M. Pulicicchio, S. Lotarski Negative allosteric modulation of metabolic glutamate receptor 5 results in broad spectrum activity relevant to treatment resistant depression [published online ahead of print April 21] Neuropharmacology 2012
54. B.L. Roth, D.J. Sheffler, W.K. Kroeze Magic shotguns versus magic bullets: Selectively non-selective drugs for mood disorders and schizophrenia Nat Rev Drug Discov 3 2004 353 359
55. A.C. Magalhaes, H. Dunn, S.S. Ferguson Regulation of GPCR activity, trafficking and localization by GPCR-interacting proteins Br J Pharmacol 165 2012 1717 1736
56. K.W. Roche, J.C. Tu, R.S. Petralia, B. Xiao, R.J. Wenthold, P.F. Worley Homer 1b regulates the trafficking of group I metabotropic glutamate receptors J Biol Chem 274 1999 25953 25957
57. K. Kuwasako, D.L. Hay, S. Nagata, T. Hikosaka, K. Kitamura, J. Kato The third extracellular loop of the human calcitonin receptor-like receptor is crucial for the activation of adrenomedullin signalling Br J Pharmacol 166 2011 137 150
58. R. Olson, C. Dulac, P.J. Bjorkman MHC homologs in the nervous system-they haven't lost their groove Curr Opin Neurobiol 16 2006 351 357
59. J.H. Tao-Cheng, F.C. Zhou Differential polarization of serotonin transporters in axons versus soma-dendrites: An immunogold electron microscopy study Neuroscience 94 1999 821 830
60. A.M. Carneiro, R.D. Blakely Serotonin-, protein kinase C-, and Hic-5-associated redistribution of the platelet serotonin transporter J Biol Chem 281 2006 24769 24780
61. M. Inazu, H. Takeda, H. Ikoshi, M. Sugisawa, Y. Uchida, T. Matsumiya Pharmacological characterization and visualization of the glial serotonin transporter Neurochem Int 39 2001 39 49
62. H.A. Lester, Y. Cao, S. Mager Listening to neurotransmitter transporters Neuron 17 1996 807 810
63. S. Tavoulari, L.R. Forrest, G. Rudnick Fluoxetine (Prozac) binding to serotonin transporter is modulated by chloride and conformational changes J Neurosci 29 2009 9635 9643
64. M.B. Larsen, M.S. Sonders, O.V. Mortensen, G.A. Larson, N.R. Zahniser, S.G. Amara Dopamine transport by the serotonin transporter: A mechanistically distinct mode of substrate translocation J Neurosci 31 2011 6605 6615
65. V.M. Korkhov, L. Milan-Lobo, B. Zuber, H. Farhan, J.A. Schmid, M. Freissmuth, H.H. Sitte Peptide-based interactions with calnexin target misassembled membrane proteins into endoplasmic reticulum-derived multilamellar bodies J Mol Biol 378 2008 337 352
66. C.G. Tate, E. Whiteley, M.J. Betenbaugh Molecular chaperones stimulate the functional expression of the cocaine-sensitive serotonin transporter J Biol Chem 274 1999 17551 17558
67. A. El-Kasaby, H. Just, E. Malle, P.C. Stolt-Bergner, H.H. Sitte, M. Freissmuth, O. Kudlacek Mutations in the carboxyl-terminal SEC24 binding motif of the serotonin transporter impair folding of the transporter J Biol Chem 285 2010 39201 39210
68. S. Sucic, A. El-Kasaby, O. Kudlacek, S. Sarker, H.H. Sitte, P. Marin, M. Freissmuth The serotonin transporter is an exclusive client of the coat protein complex II (COPII) component SEC24C J Biol Chem 286 2011 16482 16490
69. M.W. Wendeler, J.P. Paccaud, H.P. Hauri Role of Sec24 isoforms in selective export of membrane proteins from the endoplasmic reticulum EMBO Rep 8 2007 258 264
70. C. Bonnon, M.W. Wendeler, J.P. Paccaud, H.P. Hauri Selective export of human GPI-anchored proteins from the endoplasmic reticulum J Cell Sci 123 2010 1705 1715
71. J. Kim, B. Kleizen, R. Choy, G. Thinakaran, S.S. Sisodia, R.W. Schekman Biogenesis of γ-secretase early in the secretory pathway J Cell Biol 179 2007 951 963
72. A. Baudry, S. Mouillet-Richard, B. Schneider, J.M. Launay, O. Kellermann miR-16 targets the serotonin transporter: A new facet for adaptive responses to antidepressants Science 329 2010 1537 1541
73. J.L. Warner-Schmidt, E.Y. Chen, X. Zhang, J.J. Marshall, A. Morozov, P. Svenningsson, P. Greengard A role for p11 in the antidepressant action of brain-derived neurotrophic factor Biol Psychiatry 68 2010 528 535
74. A. Baudry, S. Mouillet-Richard, J.M. Launay, O. Kellermann New views on antidepressant action Curr Opin Neurobiol 21 2011 858 865
75. M.A. Sutton, A.M. Taylor, H.T. Ito, A. Pham, E.M. Schuman Postsynaptic decoding of neural activity: eEF2 as a biochemical sensor coupling miniature synaptic transmission to local protein synthesis Neuron 55 2007 648 661
76. A.E. Autry, M. Adachi, E. Nosyreva, E.S. Na, M.F. Los, P.F. Cheng NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses Nature 475 2011 91 95
77. R.J. Liu, F.S. Lee, X.Y. Li, F. Bambico, R.S. Duman, G.K. Aghajanian Brain-derived neurotrophic factor Val66Met allele impairs basal and ketamine-stimulated synaptogenesis in prefrontal cortex Biol Psychiatry 71 2012 996 1005
78. B. Ye, Y. Zhang, W. Song, S.H. Younger, L.Y. Jan, Y.N. Jan Growing dendrites and axons differ in their reliance on the secretory pathway Cell 130 2007 717 729
79. T. Cui-Wang, C. Hanus, T. Cui, T. Helton, J. Bourne, D. Watson Local zones of endoplasmic reticulum complexity confine cargo in neuronal dendrites Cell 148 2012 309 321
80. M. Aridor, A.K. Guzik, A. Bielli, K.N. Fish Endoplasmic reticulum export site formation and function in dendrites J Neurosci 24 2004 3770 3776
81. C.A. Zarate Jr, J.B. Singh, P.J. Carlson, N.E. Brutsche, R. Ameli, D.A. Luckenbaugh A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression Arch Gen Psychiatry 63 2006 856 864
82. N. Li, B. Lee, R.J. Liu, M. Banasr, J.M. Dwyer, M. Iwata mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists Science 329 2010 959 964
83. C.R. Maxwell, R.S. Ehrlichman, Y. Liang, D. Trief, S.J. Kanes, J. Karp, S.J. Siegel Ketamine produces lasting disruptions in encoding of sensory stimuli J Pharmacol Exp Ther 316 2006 315 324
84. J.A. Clements, W.S. Nimmo Pharmacokinetics and analgesic effect of ketamine in man Br J Anaesth 53 1981 27 30
85. J.F. MacDonald, M.C. Bartlett, I. Mody, P. Pahapill, J.N. Reynolds, M.W. Salter Actions of ketamine, phencyclidine and MK-801 on NMDA receptor currents in cultured mouse hippocampal neurones J Physiol 432 1991 483 508
86. B. Hille Local anesthetics: Hydrophilic and hydrophobic pathways for the drug-receptor reaction J Gen Physiol 69 1977 497 515
87. R.B. Campenot, K. Lund, S.A. Mok Production of compartmented cultures of rat sympathetic neurons Nat Protoc 4 2009 1869 1887
88. R. Srinivasan, R. Pantoja, F.J. Moss, E.D.W. Mackey, C. Son, J. Miwa, H.A. Lester Nicotine upregulates α4β2 nicotinic receptors and ER exit sites via stoichiometry-dependent chaperoning J Gen Physiol 137 2011 59 79
89. M. Aridor Visiting the ER: The endoplasmic reticulum as a target for therapeutics in traffic related diseases Adv Drug Deliv Rev 59 2007 759 781
90. S.B. Powell, T.J. Sejnowski, M.M. Behrens Behavioral and neurochemical consequences of cortical oxidative stress on parvalbumin-interneuron maturation in rodent models of schizophrenia Neuropharmacology 62 2012 1322 1331
91. D.A. Lewis, A.A. Curley, J.R. Glausier, D.W. Volk Cortical parvalbumin interneurons and cognitive dysfunction in schizophrenia Trends Neurosci 35 2012 57 67
92. H.K. Manji, J.A. Quiroz, J. Sporn, J.L. Payne, K. Denicoff, A.N. Gray Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for difficult-to-treat depression Biol Psychiatry 53 2003 707 742
93. J.M. Miwa, I. Ibanez-Tallon, G.W. Crabtree, R. Sanchez, A. Sali, L.W. Role, N. Heintz Lynx1, an endogenous toxin-like modulator of nicotinic acetylcholine receptors in the mammalian CNS Neuron 23 1999 105 114
94. A.E. Autry, L.M. Monteggia Brain-derived neurotrophic factor and neuropsychiatric disorders Pharmacol Rev 64 2012 238 258
95. R.S. Duman, B. Voleti Signaling pathways underlying the pathophysiology and treatment of depression: Novel mechanisms for rapid-acting agents Trends Neurosci 35 2012 47 56
96. B. Schwappach An overview of trafficking and assembly of neurotransmitter receptors and ion channels Mol Membr Biol 25 2008 270 278
97. E. Nosyreva, E.T. Kavalali Activity-dependent augmentation of spontaneous neurotransmission during endoplasmic reticulum stress J Neurosci 30 2010 7358 7368
98. N. Badiola, C. Penas, A. Minano-Molina, B. Barneda-Zahonero, R. Fado, G. Sanchez-Opazo Induction of ER stress in response to oxygen-glucose deprivation of cortical cultures involves the activation of the PERK and IRE-1 pathways and of caspase-12 Cell Death Dis 2 2011 e149
99. A.C. Horton, M.D. Ehlers Dual modes of endoplasmic reticulum-to-Golgi transport in dendrites revealed by live-cell imaging J Neurosci 23 2003 6188 6199
100. O. Jeyifous, C.L. Waites, C.G. Specht, S. Fujisawa, M. Schubert, E.I. Lin SAP97 and CASK mediate sorting of NMDA receptors through a previously unknown secretory pathway Nat Neurosci 12 2009 1011 1019